Skip to content
Cryptos: 553Market Cap: $2.87T 1.3%24h Vol: $129.14BDominance: BTC 58.1% ETH 10.5%
Open Tradzy

New high · Sweden stocks

Egetis Therapeutics AB (publ) (EGTX) closes at a 52-week high of SEK 9.93

Its third new 52-week high in 5 sessions. Up 25.9% over 20 sessions.

Published 9 October 2026 · Written from Tradzy's price and volume data

Close
SEK 9.93
On the day
+0.8%
Volume
0.5× average
vs 52-week high
New high

Egetis Therapeutics AB (publ) closing prices

SEK 6.00SEK 8.00SEK 10.00Jun '26Jul '26Jul '26Aug '26Sep '26Oct '26SEK 9.93

The last 90 closes up to 9 October 2026. The live chart is on the EGTX page.

What happened

Egetis Therapeutics AB (publ) (EGTX) closed at SEK 9.93 on 9 October 2026, up 0.8% from SEK 9.85 the session before.

It was the second higher close in a row. It is the third new high in the last 5 sessions. Over 5 sessions the price is up 8.2%, and over 20 sessions it is up 25.9%.

That close is above every close of the past year. The previous highest was SEK 9.85 on 8 Oct 2026, and the new close is 0.8% above it.

Trading was light: volume was 51% of its recent average.

Across the 31 STOCKHOLM stocks we track, 24 closed higher and 7 closed lower that day, with a median change of +1.35%. EGTX's change was +0.8%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeSEK 9.85
CloseSEK 9.93
Change on the day+0.81%
Change over 5 sessions+8.17%
Change over 20 sessions+25.86%
Volume2.15 Million
Average volume, up to 20 sessions before4.22 Million
Volume against that average0.5 times
Highest close in the past yearSEK 9.85 (8 Oct 2026)
Lowest close in the past yearSEK 4.32 (26 Nov 2025)

The full chart and history are on Egetis Therapeutics AB (publ) (EGTX). More from this market: STOCKHOLM news today.

More STOCKHOLM moves on 9 October 2026

Want a plan for EGTX? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.